RETINAL PIGMENT EPITHELIUM CELL COMPOSITIONS
Presented herein are ready to administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions for the treatment of retinal degenerative diseases and injuries. A method of formulating human RPE cells for administration to a subject directly after thawing and of formulating RPE cell therap...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
25.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Presented herein are ready to administer (RTA) retinal pigment epithelium (RPE) cell therapy compositions for the treatment of retinal degenerative diseases and injuries. A method of formulating human RPE cells for administration to a subject directly after thawing and of formulating RPE cell therapy compositions for cryopreservation and administration of the cryopreserved composition to a subject subsequent to thawing are also presented. In another aspect, the RTA composition may be formulated as a thaw and inject (TAI) composition, whereby the composition is administered by injection subsequent to thawing. |
---|---|
Bibliography: | Application Number: EP20210215492 |